Grant Value: up to $600,000 based on stage and scope of research
Application deadline - Letter of intent: May 28, 2021 at 5 p.m. EST
Application deadline: July 30, 2021 at 5 p.m. EST
The aim of this Request For Proposal is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. It prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use.